Your SlideShare is downloading. ×
Future Horizons in the Japanese Cancer Diagnostics Market:Supplier Shares and Sales Forecasts for 40 Tumor Markers byMarke...
Major points covered in Table of Contents of this report includeIntroductionWorldwide Market and Technology OverviewA. Can...
23. TdT24. Thyroglobulin25. Tissue Polypeptide Antigen (TPA)26. Biochemical Tumor Markers- ADA- B-Protein- PNP- 5-Nucleoti...
30. Colony Stimulating Factors31. Lymphokines- Alpha-Interferon- B Cell Growth Factors- B Cell Growth Factor (BCGF)- Gamma...
- Gastrin-Releasing Peptide (GRP)- GDCFP-15- Glucagon- Glycoamines- H23- Her-2- Human Carcinoma Antigen- HPA- HSP27- Inter...
- RB Inactivation/Deletion- Ret- SCCL 175- Selectin- Sialic Acid- Sialyl SSEA-1/SLX- SN10- Somatostatin- TA-90- TABA- Tach...
23. Roche Cobas c31124. Siemens ADVIA Centaur25. Siemens Dimension26. Siemens Dimension RxL Max27. Siemens Dimension Vista...
- QBR- SDA- 3 SR, and others4. Chromosome Analysisa. Chronic Myelogenous Leukemia (CML)b. Acute Myeloid Leukemia (AML)c. A...
5. Emerging Suppliers6. Major Types of Distributors7. Market Segmentation FactorPotential Market Entry Barriers and RisksA...
- Myriad Genetics- Nanogen Elitech- OncoLab- Otho-Clinical Diagnostics- Panacea Pharmaceuticals- Polartechnics- Polymedco-...
Calcitonin TestsMajor Companies Developing or MarketingCEA TestsMajor Companies Developing or MarketingEstrogen Receptor T...
Applications in Cancer DiagnosisExecutive Summary Table: Japan, Total TumorMarker Test Volume and Sales Forecast byMarket ...
Japan, CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Calcitonin Test Volume and DiagnosticsSale...
Japan, Nucleolar Test Volume andDiagnostics Sales Forecast by MarketSegmentList of Tables (continued)Japan, Occult Blood T...
Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, ThyroglobulinTest Volume and DiagnosticsSales Forecast b...
Upcoming SlideShare
Loading in...5
×

Future Horizons in the Japanese Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment

149

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
149
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Future Horizons in the Japanese Cancer Diagnostics Market: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Market Segment"

  1. 1. Future Horizons in the Japanese Cancer Diagnostics Market:Supplier Shares and Sales Forecasts for 40 Tumor Markers byMarket SegmentReport Details:Published:August 2012No. of Pages: 590Price: Single User License – US$6700Highlights•Comprehensive 590-page analysis of the Japanese tumor marker testing market.•Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.•Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.•Ten-year test volume and sales forecasts over for 40 tumor marker performed in Japanese hospitals, commercial laboratories and physician offices.•Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.•Current instrumentation technologies and feature comparison of leading analyzers.•Sales and market shares of leading suppliers.•Emerging diagnostic technologies and their potential market applications.•Product development opportunities.•Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.•Business opportunities and strategic recommendations for suppliers.Contains: 590 pages and 95 tables.Get your copy of this report @http://www.reportsnreports.com/reports/187741-future-horizons-in-the-japanese-cancer-diagnostics-market-supplier-shares-and-sales-forecasts-for-40-tumor-markers-by-market-segment.html
  2. 2. Major points covered in Table of Contents of this report includeIntroductionWorldwide Market and Technology OverviewA. Cancer Statistics and Etiology1. Brest Cancer2. Lung Cancer3. Colon and Rectum Cancer4. Prostate Cancer5. Stomach Cancer6. Leukemia7. Lymphoma8. Oral Cancer9. Skin Cancer10. Uterine Cancer11. Ovarian Cancer12. Bladder CancerB. Major Current And Emerging Cancer Diagnostic Tests1. Introduction2. Tumor Marker Classification3. ACTH4. Alpha-Fetoprotein (AFP)5. Beta-2 Microglobulin6. CA 15-3/27.297. CA 19-98. CA-1259. Calcitonin10. Carcinoembrionic Antigen (CEA)11. Estrogen and Progesterone Receptors12. Ferritin13. Gastrin14. Human Chorionic Gonadotropin (HCG)15. Insulin16. NSE17. Occult Blood18. PAP Smear/HPV19. Prostatic Acid Phosphatase (PAP)20. Prostate-Specific Antigen (PSA)21. Squamous Cell Carcinoma Antigen (SCC)22. T and B Lymphocytes
  3. 3. 23. TdT24. Thyroglobulin25. Tissue Polypeptide Antigen (TPA)26. Biochemical Tumor Markers- ADA- B-Protein- PNP- 5-Nucleotidase27. Oncogenes- Abl/abl-bcr- AIB1- BCL-2- BRCA1- CD44- C-fos- C-myb- C-myc- CYP-17- Erb-B- HPC1- N-myc- P40- P51- P53- PIK3CA- PTI-1- Ras- Reg- Sis- Src28. Polypeptide Growth Factors- Basic Fibroblast Growth Factor- Beta-TGF- Cachectin (TNT)- Calmodulin- ECFR- Nerve Growth Factor (NGF)- Epidermal Growth Factor (EGF)- Ornithine Decarboxylase- Transferrin- Transforming Growth Factor-Alpha29. Ectopic Hormones
  4. 4. 30. Colony Stimulating Factors31. Lymphokines- Alpha-Interferon- B Cell Growth Factors- B Cell Growth Factor (BCGF)- Gamma-Interferon- Interleukin-1 (IL-1)- Macrophage Activating Factor32. Immunohistochemical Stains33. Emerging Tumor Markers- N-Acetylglucosamine- Actin- Alpha-Actin- Antineuronal Antibodies- 7B2- B72.3- Bax- BCD-F9- BLCA-4- Blood Group Antigens A,B,H- CA 50- CA 72-4/TAG-72- CA 195- CA-242- CA-549- CAM 26- CAR-3- Cathepsin-D- Chromogranin A and B- Cluster 1 Antigen- Cluster-5/5A Antigen- CTA- CU18- DR-70- DU-PAN-2- Endometrial Bleeding Associated Factor- Endostatin- Epithelial Membrane Antigen- Feulgen Hydrolysis- Fibronectin- FSH- (1->3)-L-fucosyltransferase
  5. 5. - Gastrin-Releasing Peptide (GRP)- GDCFP-15- Glucagon- Glycoamines- H23- Her-2- Human Carcinoma Antigen- HPA- HSP27- Intermediate Filaments- Cytokeratins/CK18/Cyfra 21-1- Desmin- Gliofibrillary Acid Protein- Neurofilaments- Vimentin- KA 93- Kinases- KP16D3- LAI- Leukocyte Common Antigen- Lewis Antigens- Lysophosphatidic Acid (LPA)- Ma 695/Ma 552- MABDF3- MAG- ME1- Minactivin- MN/CA9- MSA- Mucin Cancer Antigen (MCA)- Multiple Tumor Suppressor 1- Myosin- NEA-130- NMP22- OA-519- Opiod Peptides- P-glycoprotein- Pancreatic Oncofetal Antigen (POA)- Placental Lactogen- PR92- Proliferative Index, Ki-67- Px
  6. 6. - RB Inactivation/Deletion- Ret- SCCL 175- Selectin- Sialic Acid- Sialyl SSEA-1/SLX- SN10- Somatostatin- TA-90- TABA- Tachykinin- TAG 12- TPS- Troponin- Tubulin- VCAM- VEGF- VillenC. Instrumentation Review And Market Needs1. Abbott AxSYM2. Abbott Architect c40003. Abbott Architect i2000 Series4. Abbott Architect ci8200 System5. Beckman Coulter UniCel Series6. Beckman Coulter Access7. Binding Site ESP6008. bioMerieux Mini Vidas9. Carolina Chemistries BioLis 24i10. DiaSorin Liaison11. Horiba ABX Pentra 40012. Inverness DS213. J&J Vitros ECi/ECiQ14. J&J Vitros 360015. J&J Vitros 560016. Olympus AU540017. Olympus AU3000i18. Olympus AU270019. Roche Modular Analytics20. Roche Cobas Integra 40021. Roche Cobas Integra 400 Plus22. Roche Elecsys
  7. 7. 23. Roche Cobas c31124. Siemens ADVIA Centaur25. Siemens Dimension26. Siemens Dimension RxL Max27. Siemens Dimension Vista 50028. Siemens Immulite29. Siemens Stratus30. Tosoh AIA-Series31. Vital Diagnostics ATAC 800032. Vital Diagnostics Envoy 500D. Current and Emerging Technologies1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principleb. Radioimmunoassay (RIA)c. Enzyme Immunoassays (EIA)- Overview- ELISA- Immunofiltration- Particle-Membrane Capture Immunoassay- Enzyme Amplificationd. Fluorescent Immunoassayse. Luminescence- Chemiluminescence- Bioluminescencef. Latex Agglutinationg. ImmunoprecipitationH. Affinity Chromatographue. Liposome Flow-Injection Immunoassay3. Molecular Diagnosticsa. Technology Overviewb. Amplification Methods- PCR- DAP-PCR- Immuno-PCR- QC-PCR- CAR- DNA- HPA- LCR- NASBA
  8. 8. - QBR- SDA- 3 SR, and others4. Chromosome Analysisa. Chronic Myelogenous Leukemia (CML)b. Acute Myeloid Leukemia (AML)c. Acute Lymphoblastic Leukemia (ALL)d. Malignant Lymphomas Lymphoid Malignanciese. Chronic Lymphocytic Leukemia (CLL)f. Solid Cancersg. Chromosomal Translocation and Oncogenes5. Artificial Intelligence6. Flow Cytometry7. Two Dimensional Gel Electrophoresis (2-DGE)8. Biosensors9. Competing/Complementing Technologiesa. CTb. MRIc. NMRd. PETe. Photonics SpectroscopyE. Personal TestingJapanA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersMajor Product Development OpportunitiesA. Reagent Kits and Test Systems/PanelsB. InstrumentationC. Computers, Software and AutomationD. Auxiliary ProductsDesign Criteria for Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers
  9. 9. 5. Emerging Suppliers6. Major Types of Distributors7. Market Segmentation FactorPotential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive Profiles- Abbott- AdnaGen- Applied Gene Technologies- Arca- Beckman Coulter/Danaher- Becton Dickinson- Biomedical Diagnostics- bioMerieux- Bio-Rad- Cepheid- Correlogic Systems- Dako- Decode- Diadexus- Diagnocure- Diasorin- Eiken Chemical- Enterix- Enzo Biochem- Epigenomics- Exact Sciences- Fujirebio- Gen-Probe- Guided Therapeutics- Hologic- Ipsogen- Kreatech- Kyowa Medex- Life Technologies- Mackay Life Sciences
  10. 10. - Myriad Genetics- Nanogen Elitech- OncoLab- Otho-Clinical Diagnostics- Panacea Pharmaceuticals- Polartechnics- Polymedco- PreMD- Qiagen- Radient Pharmaceuticals- Roche- Scienion- Sequenom- Siemens Healthcare- Takara Bio- Targeted Diagnostics & Therapeutics- Tosoh- Veridex- Wako Pure Chemicals- Wallac/PE- ZilaAppendixesAppendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technologyand ApplicationsAppendix II: Assumed Currency Exchange RatesList of TablesTumor Marker ClassificationMajor Companies Developing or MarketingACTH TestsMajor Companies Developing or MarketingAFP TestsMajor Companies Developing or MarketingBeta-2 Microglobulin TestsMajor Companies Developing or MarketingCA 15-3/27.29 TestsMajor Companies Developing or MarketingCA 19-9 TestsMajor Companies Developing or MarketingCA 125 TestsMajor Companies Developing or Marketing
  11. 11. Calcitonin TestsMajor Companies Developing or MarketingCEA TestsMajor Companies Developing or MarketingEstrogen Receptor TestsMajor Companies Developing or MarketingProgesterone Receptor TestsMajor Companies Developing or MarketingFerritin TestsMajor Companies Developing or MarketingGastrin TestsList of Tables (continued)Major Companies Developing or MarketingHCG TestsMajor Companies Developing or MarketingInsulin TestsMajor Companies Developing or MarketingNSE TestsMajor Companies Developing or MarketingOccult Blood TestsMajor Companies Developing or MarketingPAP Smear/HPV TestsMajor Companies Developing or MarketingPAP TestsMajor Companies Developing or MarketingPSA TestsMajor Companies Developing or MarketingLymphocyte Subclassification TestsBiochemical Markers Potential ApplicationsIn Cancer DiagnosisOncogenes Potential ApplicationsIn Cancer DiagnosisMajor Companies Developing or MarketingOncogene TestsGrowth Factors Potential ApplicationsIn Cancer DiagnosisColony Stimulating Factors PotentialApplications in Cancer DiagnosisLymphokines Potential ApplicationsIn Cancer DiagnosisList of Tables (continued)Immunohistochemical Stains Potential
  12. 12. Applications in Cancer DiagnosisExecutive Summary Table: Japan, Total TumorMarker Test Volume and Sales Forecast byMarket SegmentJapan, Estimated Cancer Death RatesPer 100,000 PopulationJapan, Laboratories Performing TumorMarker Tests by Market SegmentJapan, Hospital Laboratories PerformingTumor Marker Tests by Bed SizeCommercial/Private LaboratoriesPerforming Tumor Marker TestsBy Annual Test VolumeJapan, Total Tumor Marker Testing VolumeForecast by Market SegmentJapan, All Market Segments Major TumorMarker Test Volume ForecastJapan, Hospital Laboratories Major TumorMarker Test Volume Forecast by TestJapan, Commercial/Private Laboratories MajorTumor Marker Test Volume ForecastJapan, Total Tumor Marker SalesForecast by Market SegmentJapan, All Market Segments Major TumorMarker Sales Forecast by TestJapan, Hospital Laboratories Major TumorMarker Sales Forecast by TestList of Tables (continued)Japan, Commercial/Private Laboratories MajorTumor Marker Sales Forecast by TestJapan, ACTH Test Volume and Diagnostics SalesForecast by Market SegmentJapan, AFP Test Volume and Diagnostics SalesForecast by Market SegmentJapan, Beta-2 Microglobulin Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, CA 15-3/27.29 Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, CA 19-9 Test Volume and DiagnosticsSales Forecast by Market Segment
  13. 13. Japan, CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Calcitonin Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Cathepsin Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, CEA Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Chromogranin Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Colon-Specific Antigen Test VolumeAnd Diagnostics Sales Forecast by MarketSegmentList of Tables (continued)Japan, Cytokeratins Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Estrogen Receptor Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Ferritin Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Gastrin Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, HCG Test Volume and Diagnostics SalesForecast by Market SegmentJapan, Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Interferons Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Interleukins Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Lymphocyte Subtyping Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, NSE Test Volume and Diagnostics SalesForecast by Market Segment
  14. 14. Japan, Nucleolar Test Volume andDiagnostics Sales Forecast by MarketSegmentList of Tables (continued)Japan, Occult Blood Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Oncogenes Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Pancreatic Oncofetal AntigenTest Volume and DiagnosticsSales Forecast by Market SegmentJapan, PAP Smear Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Parathyroid HormoneTest Volume and DiagnosticsSales Forecast by Market SegmentJapan, Progesterone ReceptorTest Volume and DiagnosticsSales Forecast by Market SegmentJapan, PAP Test Volume and Diagnostics SalesForecast by Market SegmentJapan, PSA Test Volume and Diagnostics SalesForecast by Market SegmentJapan, S-100 Protein Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Serotonin Test Volume andDiagnostics Sales Forecast by MarketSegmentList of Tables (continued)Japan, Sialic Acid Test Volume andDiagnostics Sales Forecast by MarketSegmentJapan, Squamous Cell Carcinoma AntigenTest Volume and Diagnostics SalesForecast by Market SegmentJapan, TDT Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Thymidine Kinase
  15. 15. Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, ThyroglobulinTest Volume and DiagnosticsSales Forecast by Market SegmentJapan, TPA, Test Volume and DiagnosticsSales Forecast by Market SegmentJapan, Total Tumor MarkerSales by Major SuppliersJapan, AFP Testing Market DiagnosticsSales by Major SupplierJapan, CA 15-3/27.29 Testing MarketDiagnostics Sales by Major SupplierJapan, CA 19-9 Testing Market DiagnosticsSales by Major SupplierJapan, CA 125 Testing Market DiagnosticsSales by Major SupplierJapan, Calcitonin Testing Market DiagnosticsSales by Major SupplierList of Tables (continued)Japan, PAP Testing Market DiagnosticsSales by Major SupplierJapan, PSA Testing Market DiagnosticsSales by Major SupplierContact: sales@reportsandreports.com for more information.

×